Long-Term Follow-up Study for Patients Previously Treated With JCAR015
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 500
Summary
- Conditions
- Acute Lymphoblastic Leukemia
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02813252
- Collaborators
- Not Provided
- Investigators
- Study Director: Nikolaus Trede, MD, PhD JunoTherapeutics, Inc.